FDA Drug Recalls

Recalls / Class III

Class IIID-0539-2024

Product

Cephalexin for Oral Suspension, USP, 250mg per 5mL, Rx only, 100mL (when mixed), Each contains cephalexin monohydrate, USP equivalent to 5g cephalexin. Manufactured by Alkem Laboratories Ltd, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9206-1.

Brand name
Cephalexin
Generic name
Cephalexin
Active ingredient
Cephalexin
Route
Oral
NDC
63629-9206
FDA application
ANDA210221
Affected lot / code info
Lot: 235288, 235294, 235368, 235806, 236058, 236138, 236139, 236351, 236490, 236757, 236877, Exp:11/30/2025; 236758, 236762, 237254, 237349, 237401, 237807, Exp: 12/31/2025.

Why it was recalled

Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g'

Recalling firm

Firm
Bryant Ranch Prepack, Inc.
Manufacturer
Bryant Ranch Prepack
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1919 N Victory Pl, N/A, Burbank, California 91504-3425

Distribution

Quantity
190 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2024-05-10
FDA classified
2024-06-04
Posted by FDA
2024-06-12
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0539-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Cephalexin · FDA Drug Recalls